RENEF — Cartesian Growth II Balance Sheet
0.000.00%
Last trade - 00:00- $107.24m
- $115.79m
- 31
- 37
- 51
- 33
Annual balance sheet for Cartesian Growth II, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | — | 0.544 | 0.051 | 0.237 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 464 | 0.85 | 0.33 | 0.439 |
| Long Term Investments | ||||
| Total Assets | 464 | 241 | 175 | 85 |
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Current Liabilities | 442 | 0.219 | 1.53 | 3.48 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 442 | 18.9 | 18.9 | 20.7 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 21.3 | 222 | 156 | 64.3 |
| Total Liabilities & Shareholders' Equity | 464 | 241 | 175 | 85 |
| Total Common Shares Outstanding |